Evaluating Impact of Empagliflozin on Lipid Profile of Patients of Type 2 Diabetes Mellitus

• Autori principali: Nauman Wazir (Autore), Shafqat Ur Rehman (Autore)
• Natura: Libro
• Pubblicazione: Gandhara University, 2022-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

OBJECTIVES: To assess the effect of two doses, i.e., 10 mg and 25 mg of empagliflozin, on the lipid profile of patients with type 2 diabetes mellitus (T2DM) with suboptimal glycemic control on maximal doses of metformin and sitagliptin. METHODOLOGY: The study design was a randomized, open-label clin...